Chemical Compound

1H-Pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione, 4,11-diethyl-4-hydroxy-, (4S)-; 1H-Pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione, 4,11-diethyl-4-hydroxy-, (S)-; 7-Ethyl-20(S)-camptothecin; 7-Ethylcamptothecin; SN 22; Irinotecan Related Compound E; Irinotecan Hydrochloride Trihydrate Impurity F; Irinotecan Impurity F

CAS Registry Number 78287-27-1
返回搜索 申请报价
1H-Pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione, 4,11-diethyl-4-hydroxy-, (4S)-; 1H-Pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione, 4,11-diethyl-4-hydroxy-, (S)-; 7-Ethyl-20(S)-camptothecin; 7-Ethylcamptothecin; SN 22; Irinotecan Related Compound E; Irinotecan Hydrochloride Trihydrate Impurity F; Irinotecan Impurity F 结构式
Primary record

1H-Pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione, 4,11-diethyl-4-hydroxy-, (4S)-; 1H-Pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione, 4,11-diethyl-4-hydroxy-, (S)-; 7-Ethyl-20(S)-camptothecin; 7-Ethylcamptothecin; SN 22; Irinotecan Related Compound E; Irinotecan Hydrochloride Trihydrate Impurity F; Irinotecan Impurity F

库存
5,712 克
纯度
98.6 %
CAS
78287-27-1

化合物标识与属性

CAS
78287-27-1
PubChem CID
127584
SMILES
CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)[C@@]4(CC)O)C2=NC5=CC=CC=C51
Canonical SMILES
CCc1c2c(nc3ccccc13)-c1cc3c(c(=O)n1C2)COC(=O)[C@]3(O)CC

名称与同义词

  • 7-Ethylcamptothecin
  • 7-Ethyl camptothecin
  • 78287-27-1
  • 7-ethyl-camptothecin
  • LPY7FE51IW
  • Irinotecan USP Rc E
  • AC1Q6APY
  • RefChem:106074
  • UNII-LPY7FE51IW
  • Irinotecan EP Impurity F
  • SN-22
  • CHEMBL837
  • 7-Ethyl-20(S)-camptothecin
  • AC1L2S9N
  • C22H20N2O4
  • SN 22
  • MFCD06657922
  • Irinotecan Related Compound E
  • DTXSID60228960
  • MYQKIWCVEPUPIL-QFIPXVFZSA-N
  • 7-Ethylcamptothecin (Standard)
  • AC1Q2T75
  • CHEMBL420146
  • orb1303366
  • SCHEMBL1005149
  • SCHEMBL4979100
  • 7-Ethyl-10-hydroxycamptothecin
  • 7-Ethylcamptothecin, AldrichCPR
  • SCHEMBL29363060
  • HY-N2108R
  • 7-Ethyl-10-hydroxy-camptothecin
  • DTXCID10151451
  • (S)-4,11-Diethyl-4-hydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione
  • CHEBI:191009
  • KST-1A8421
  • SN-38
  • AMY24894
  • HY-N2108
  • ZINC5140293
  • ANW-58095
  • AR-1A6073
  • BDBM50092821
  • CE-007
  • CID127584
  • s5111
  • AKOS015909654
  • C22-H20-N2-O4
  • AC-1267
  • ACN-035264
  • CCG-268367
  • CS-O-30626
  • EBC-615354
  • KS-5291
  • RL05034
  • 7-Ethyl-10-hydroxy-20(S)-camptothecin
  • AJ-53303
  • AK-88554
  • AN-15094
  • BC200254
  • S412
  • SY013195
  • 7-ETHYLCAMPTOTHECIN [USP IMPURITY]
  • AB0018621
  • AB3000018
  • J448.356A
  • TC-146840
  • CS-0018629
  • E0781
  • ST24036156
  • 7-Ethylcamptothecin, 98% - 100MG 100mg
  • H11443
  • IRINOTECAN RELATED COMPOUND E [USP-RS]
  • M-1090
  • (19S)-10,19-diethyl-19-hydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4,6,8,10,15(20)-heptaene-14,18-dione
  • (S)-4,11-Diethyl-4-hydroxy-1H-pyrano[3',4'
  • 287E271
  • A865061
  • I14-3232
  • (4s)-4,11-diethyl-4-hydroxy-1h-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4h,12h)-dione
  • Irinotecan EP Impurity F; Camptothecin 7-Ethyl Impurity
  • B2703-464837
  • (S)-4,11-Diethyl-4-hydroxy-1H-pyrano(3',4':6,7)indolizino(1,2-b)quinoline-3,14(4H,12H)-dione
  • 1H-Pyrano(3',4':6,7)indolizino(1,2-b)quinoline-3,14(4H,12H)-dione, 4,11-diethyl-4-hydroxy-, (S)-
  • (19S)-10,19-diethyl-19-hydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.0^{2,11}.0^{4,9}.0^{15,20}]henicosa-1(21),2,4,6,8,10,15(20)-heptaene-14,18-dione
  • 82801-73-8
  • (19S)-10,19-DIETHYL-19-HYDROXY-17-OXA-3,13-DIAZAPENTACYCLO[11.8.0.0(2),(1)(1).0?,?.0(1)?,(2)?]HENICOSA-1(21),2,4,6,8,10,15(20)-HEPTAENE-14,18-DIONE
  • (19S)-10,19-diethyl-19-hydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.0?,??.0?,?.0??,??]henicosa-1(21),2,4,6,8,10,15(20)-heptaene-14,18-dione
  • (19S)-10,19-diethyl-19-hydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.0^{2,11.0^{4,9.0^{15,20]henicosa-1(21),2,4,6,8,10,15(20)-heptaene-14,18-dione
  • (19S)-10,19-diethyl-19-hydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.0^{2,11}.0^{4,9}.0^{15,20}]henicosa-1(21),2(11),3,5,7,9,15(20)-heptaene-14,18-dione
  • (19S)-10,19-diethyl-19-hydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2(11),3,5,7,9,15(20)-heptaene-14,18-dione
  • (4S)-4,11-Diethyl-4-hydroxy-3,4,12,14-tetrahydro-1H-pyrano[3 ,4 :6,7]indolizino[1,2-b]quinoline-3,14-dione
  • (4S)-4alpha,11-Diethyl-4-hydroxy-1H-pyrano[3 ,4 :6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione
  • (R)-4-Ethyl-4-methyl-1,4a,12,13a-tetrahydro-4H-2-oxa-6,12a-diaza-dibenzo[b,h]fluorene-3,13-dione
  • (S)-4,11-Diethyl-4,9-dihydroxy-1,5,5a,12-tetrahydro-4H-2-oxa-6,12a-diaza-dibenzo[b,h]fluorene-3,13-dione
  • (S)-4,11-Diethyl-4-hydroxy-1,12-dihydro-4H-2-oxa-6,12a-diaza-dibenzo[b,h]fluorene-3,13-dione
  • (S)-4,11-DIETHYL-4-HYDROXY-1H-PYRANO(3,4:6,7)INDOLIZINO(1,2-B)QUIN OLINE-3,14(4H,12H)-DIONE
  • (S)-4,11-Diethyl-4-hydroxy-1H-pyrano[3 inverted exclamation mark ,4 inverted exclamation mark :6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione
  • (S)-4,11-Diethyl-4-hydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione (7-Ethyl-20(S)-camptothecin)
  • 1H-PYRANO(3',4':6,7)INDOLIZINO(1,2-B)QUINOLINE-3,14(4H,12H)-DIONE, 4,11-DIETHYL-4-HYDROXY-, (4S)-
  • 1H-Pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione, 4,11-diethyl-4-hydroxy-, (4S)-; 1H-Pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione, 4,11-diethyl-4-hydroxy-, (S)-; 7-Ethyl-20(S)-camptothecin; 7-Ethylcamptothecin; SN 22; Irinotecan Related Compound E; Irinotecan Hydrochloride Trihydrate Impurity F; Irinotecan Impurity F
  • 4,11-diethyl-4,9-dihydroxy-(4S)-3,4,12,14-tetrahydro-1H-pyrano[3'',4'':6,7]indolizino[1,2-b]quinoline-3,14-dione
  • 4,11-Diethyl-4,9-dihydroxy-1,12-dihydro-4H-2-oxa-6,12a-diaza-dibenzo[b,h]fluorene-3,13-dione
  • 4,11-Diethyl-4,9-dihydroxy-1,12-dihydro-4H-2-oxa-6,12a-diaza-dibenzo[b,h]fluorene-3,13-dione (SN-38)
  • 4,11-Diethyl-4-hydroxy-1,12-dihydro-4H-2-oxa-6,12a-diaza-dibenzo[b,h]fluorene-3,13-dione
  • 680-163-8